John C. Chabala, Ph.D.
Former Chief Scientific Officer, Pharmacopeia, Inc.
Dr. Chabala is a founder of Pharmacopeia, Inc., where he served as President from 1993 to 1996, Chief Scientific Officer from 1993 to 1997, and a member of the Board of Directors from 1993 to 1996. Before joining Pharmacopeia, Dr. Chabala was Vice President of Discovery Chemistry at Bristol-Myers Squibb from 1991 to 1993, where he supervised worldwide medicinal chemistry activities. From 1975 to 1991 he was with Merck Sharp & Dohme, ultimately as Executive Director of Basic Chemistry, supervising a variety of medicinal chemistry programs as well as Biophysical Chemistry and Natural Products Chemistry. He is a co-inventor of ivermectin, one of the largest selling parasiticides. Dr. Chabala earned his Ph.D. in organic chemisty at the Massachusetts Institute of Technology in 1975.
